Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE

Recruiting now · Phase 3

Conditions studied: Nocturnal Enuresis in Children

In brief

The goal of this clinical trial is to compare combination of Solifenacin and MIrabegron in treatment of primary mono-symptomatic nocturnal enuresis in children. It will also learn about the safety of that combination. The main questions it aims to answer are: Does combination of Solifenacin and MIrabegron lower the number of wet nights? What medical problems do participants have when taking combination of Solifenacin and MIrabegron? Researchers will compare the combination to omegapress to see if the combination works better to treat primary mono-symptomatic nocturnal enuresis. Participants will: Take the combination or Omegapress every day for 3 months Visit the clinic once monthly for checkups and tests Keep a diary of their symptoms and the number of wet nights

Key facts

Study ID

NCT07199894

Run by

Mansoura University

People needed

120

Starts

2024-12-01

Expected to finish

2026-02-01

Last updated by the study team

2025-09-30

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary mono-symptomatic nocturnal enuresis -

You may not qualify if…

• Bowel dysfunction Psychatric illness Respiratory sleep disorders

Where it is running

• Urology and Nephrology center - Mansoura University — Al Mansurah, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.